Recipharm Annual report 2012

"2012 – a year of records in the history of Recipharm"

In 2012 we delivered a record operating profit, record operating margin, record return on capital and a strong cash flow. Last year, I commented on how we responded to major business challenges through a number of reshaping initiatives. This year, we not only saw the effect of these initiatives but we also continued to make operating improvements and took further important steps to strengthen Recipharm for today and the future.